SCHEMBL18630403

SCHEMBL18630403

Fn1c2ccccc2c2c3sc4ccccc4c3ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.42
▸ MAPT P10636 4/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ TNKS2 Q9H2K2 3/20 0.34
▸ TNKS O95271 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ PARP14 Q460N5 1/20 0.33
▸ ERCC5 P28715 1/20 0.32
▸ FEN1 P39748 1/20 0.32
▸ LIMK1 P53667 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18435665 0.82 GPR3 (0.41) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL13183789 0.82 GPR3 (0.47) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL24676551 0.81 GPR3 (0.39) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL10014516 0.81 ATM (0.43) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL4554296 0.80 ATM (0.50) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL24676247 0.80 GPR3 (0.38) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL17246560 0.80 ATM (0.46) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL16171206 0.78 ALOX5 (0.38) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL21304050 0.78 ALDH1A1 (0.46) GPR3MAPTRAB9AALDH1A1HPGD
SCHEMBL18566532 0.78 GPR3 (0.37) GPR3MAPTRAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10249830-B2 Carbazole-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-04-02 — — US disclosed
US-20170077419-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10249830-B2 Carbazole-based compound and organic light-emitting device including the same OCIAD1, OXA1L, OCIAD2 GPR3 907/4885MAPT 1393/4885RAB9A 1253/4885
US-20170077419-A1 CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME OCIAD1, OXA1L, CYP1A1 GPR3 679/4885MAPT 1280/4885RAB9A 1654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback